Brief: Fivet Investment Management Ltd Reports 6.03% Stake In Inhibikase Therapeutics
11/01/2022 17:07
Jan 11 (Reuters) - Inhibikase Therapeutics Inc IKT.O :
* FIVET INVESTMENT MANAGEMENT LTD REPORTS 6.03% STAKE IN
INHIBIKASE THERAPEUTICS INC AS OF JANUARY 10, 2022 - SEC FILING
Further company coverage: IKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share
Brief: Inhibikase Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Brief: Inhibikase Therapeutics Advancing IKT-001 To Global Phase 3 Study In Pulmonary Arterial Hypertension
Cardiopulmonary drugmaker Inhibikase Therapeutics' Q3 net loss widens
Inhibikase Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary